C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) C07K 16/00 (2006.01) C07K 16/46 (2006.01) C07K 19/00 (2006.01) C12N 9/00 (2006.01) C12N 15/13 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2128511
The present invention describes a new class of antigen binding molecules which contain Fv-fragments of an antibody but do not use the constant antibody domains. They can also dimerize with other antibody fragment molecules or with non-antibody fragment molecules to form bi- or multifunctional antibody-fragment fusion proteins and so-called miniantibodies, respectively. The new fusion proteins can be used in the broad field of diagnostic and therapeutical medicine.
Pack Peter
Pluckthun Andreas
Fetherstonhaugh & Co.
Merck Patent Gmbh
LandOfFree
Monomeric and dimeric antibody-fragment fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monomeric and dimeric antibody-fragment fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monomeric and dimeric antibody-fragment fusion proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1544655